Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/554
Title: Chronic telogen affluvium: a study of 5 patients over 7 years.
Epworth Authors: Sinclair, Rodney
Keywords: Alopecia
Hair Growth
Chronic Disease
Hypotrichosis
Scalp
Thyroid Diseases
Biopsy
Chronic Telogen Effluvium
Female Pattern Hair Loss
FPHL
Spironolactone
Chair of Dermatology, Epworth HealthCare, Victoria, Australia
Head & Neck Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Feb-2005
Publisher: Elsevier
Citation: J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):12-6.
Abstract: Chronic telogen effluvium is said to be self-limiting in the long run; the natural history of this condition, however, has not been investigated prospectively. Four women, aged between 18 and 64 years and diagnosed with chronic telogen effluvium between 1996 and 1997, were followed up prospectively for a minimum of 7 years. One (previously reported) woman diagnosed in 1998 developed female pattern hair loss confirmed on biopsy specimen within 18 months that was partially reversed by spironolactone. The remaining 4 women continued to experience chronic diffuse telogen hair shedding that fluctuated in severity. However, serial photography demonstrated no visible reduction in hair density, and serial scalp biopsy specimen showed no follicular miniaturization. Although 4 out of 5 of our patients showed no tendency toward development of female pattern hair loss or to spontaneous improvement, further work is required to define the natural history of chronic telogen effluvium and the relative risk of developing female pattern hair loss.
URI: http://hdl.handle.net/11434/554
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/15692504
ISSN: 01909622
Journal Title: Journal of The American Academy of Dermatology
Type: Journal Article
Type of Clinical Study or Trial: Case Series and Case Reports
Appears in Collections:Head & Neck
Dermatology

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.